Over the last 7 days, the United States market has remained flat, yet it has experienced a notable rise of 19% over the past year. In this environment where earnings are expected to grow by 18% annually in the coming years, identifying stocks that are estimated to be below their fair market value can offer potential opportunities for investors seeking to capitalize on future growth.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Name	Current Price	Fair Value (Est)	Discount (Est)
Southside Bancshares (SBSI)	$35.74	$70.77	49.5%
Rayonier (RYN)	$22.15	$43.21	48.7%
HBT Financial (HBT)	$33.39	$66.60	49.9%
Genuine Parts (GPC)	$125.66	$246.66	49.1%
Everpure (P)	$68.37	$135.21	49.4%
Dime Commercial Bancshares (DCOM)	$41.16	$80.68	49%
Caledonia Mining (CMCL)	$17.12	$33.53	48.9%
American Healthcare REIT (AHR)	$56.59	$111.43	49.2%
Amaroq (AMRQ.F)	$1.13	$2.24	49.6%
AAON (AAON)	$113.20	$221.74	48.9%

Underneath we present a selection of stocks filtered out by our screen.

NVIDIA (NVDA)

Overview: NVIDIA Corporation operates as a data center scale AI infrastructure company across the United States, Taiwan, China, Hong Kong, Europe, and internationally with a market cap of approximately $5.15 trillion.

Operations: The company's revenue is primarily derived from two segments: Graphics, contributing $25.05 billion, and Compute & Networking, generating $228.44 billion.

Estimated Discount To Fair Value: 12.1%

NVIDIA's recent developments highlight its robust cash flow potential, supported by strategic expansions and partnerships. The company is engaged in significant AI infrastructure projects, such as the NVIDIA Vera Rubin platform and collaborations with firms like Noetra Corp., enhancing its data center capabilities. Despite a regulatory challenge from Netlist, Inc., NVIDIA's financial performance remains strong, with substantial revenue growth and high return on equity forecasts. Current trading below estimated future cash flow value suggests potential undervaluation based on discounted cash flows.

Xometry (XMTR)

Overview: Xometry, Inc. operates an AI-powered online manufacturing marketplace both in the United States and internationally, with a market cap of approximately $5.56 billion.

Operations: The company's revenue primarily comes from its Internet Software & Services segment, totaling $740.80 million.

Estimated Discount To Fair Value: 19.1%

Xometry's strategic initiatives, including a $225 million equity offering and a partnership with Siemens, bolster its cash flow potential. The company has expanded capabilities in injection molding and data center components, enhancing revenue growth prospects. Despite recent insider selling and share price volatility, Xometry trades below its estimated future cash flow value of US$119.14 at US$96.42 per share, suggesting it may be undervalued based on discounted cash flows.

Merck (MRK)

Overview: Merck & Co., Inc. is a global healthcare company with operations spanning pharmaceuticals, vaccines, and animal health, and it has a market cap of approximately $305.29 billion.

Operations: The company's revenue is primarily derived from its Pharmaceutical segment, generating $58.85 billion, and its Animal Health segment, contributing $6.56 billion.

Estimated Discount To Fair Value: 41.9%

Merck's recent FDA approvals and strategic alliances enhance its cash flow potential. The company is involved in the Billion Cell Atlas alliance, which could drive future drug discovery. Despite a recent net loss and high debt levels, Merck trades at US$127.63, substantially below its estimated future cash flow value of US$219.68, indicating it may be undervalued based on discounted cash flows. However, profit margins have declined from last year.

Next Steps

• Click this link to deep-dive into the 157 companies within our Undervalued US Stocks Based On Cash Flows screener.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.

Ready To Venture Into Other Investment Styles?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.